Table 2.
The results of SCF and c-kit concentrations in the supgroups og aspirin hypersensitive and tolerant patients, patients with and without nasal polyps and atopic and nonatopic asthmatics.
| SCF (pg/ml) | c-kit (ng/ml) | ||||
| Aspirin hypersensitive (n = 42) | Aspirin tolerant (n = 46) | P value | Aspirin hypersensitive (n = 23) | Aspirin tolerant (n = 40) | P value |
| 959,1 +/- 44 | 980 +/- 50 | Ns | 76,9 +/- 6,8 | 71,7 +/- 5,7 | ns |
| With nasal polyps (n = 33) | Without nasal polyps (n = 55) | P value | With nasal polyps (n = 14) | Without nasal polyps (n = 49) | P value |
| 928 +/- 42,4 | 992 +/- 47,8 | Ns | 83,5 +/- 80 | 70,3 +/- 51,6 | 0,049 |
| Atopic (n = 67) | Nonatopic (n = 21) | P value | Atopic (n = 44) | Nonatopic (n = 19) | P value |
| 949,9 +/- 38 | 1033 +/- 65 | ns | 67,5 +/- 5,03 | 87 +/- 8,02 | 0,028 |